Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
2.
Thromb Res ; 157: 157-161, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28759760

ABSTRACT

INTRODUCTION: The activated partial thromboplastin time (APTT) is commonly used to monitor unfractionated heparin (UFH) but may not accurately measure the amount of heparin present. The anti-Xa assay is less susceptible to confounding factors and may be a better assay for this purpose. MATERIALS AND METHODS: The validity of the APTT for monitoring UFH was assessed by comparing with an anti-Xa assay on 3543 samples from 475 patients (infants [n=165], children 1-15years [n=60] and adults [n=250]) receiving treatment dose UFH. RESULTS: Overall concordance was poor. The highest concordance (66%; 168/254) was seen in children. Concordance (51.8%) or discordance (48.4%) was almost equal in adult patients. Among adult patients whose anti-Xa level was within 0.3-0.7IU/mL, only 38% had an APTT in the therapeutic range whilst 56% were below and 6% were above therapeutic range. Children and adult patients with anti-Xa of 0.3-0.7IU/mL but sub- therapeutic APTT had significantly higher fibrinogen levels compared to those with therapeutic or supra-therapeutic APTT. CONCLUSIONS: When the anti-Xa level was 0.3-0.7IU/mL, the majority of samples from infants demonstrated a supra-therapeutic APTT, whilst adults tended to have a sub-therapeutic APTT. This may lead to under anticoagulation in infants or over anticoagulation in adults with risk of bleeding if APTT is used to monitor UFH. These results further strengthen existing evidence of the limitation of APTT in monitoring UFH. Discordance of APTT and anti-Xa level in adults and children may be due to elevation of fibrinogen level.


Subject(s)
Heparin, Low-Molecular-Weight/therapeutic use , Partial Thromboplastin Time/methods , Female , Humans , Male
3.
Int J Lab Hematol ; 36(4): 465-71, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24325756

ABSTRACT

INTRODUCTION: Following paediatric cardiac surgery using cardiopulmonary bypass (CPB), there is a risk of significant postoperative bleeding. A number of risk factors are associated with postoperative bleeding including; age, complexity of the surgery, dilution and consumption of clotting factors. We conducted a prospective audit comparing different coagulation tests used following paediatric CPB to determine whether thromboelastography (TEG) on the intensive care unit or routine laboratory coagulation assays including fibrinogen are better at assessing bleeding and bleeding risk. METHODS: Tests on arrival in paediatric intensive care unit (PICU) included the following: fibrinogen, prothrombin time, activated partial thromboplastin time, full blood count and TEG. Bleeding was measured in the first 1-4 h via chest drain loss. Bleeding was considered significant if ≥5 ml/kg/h. RESULTS: Of 107 patients admitted to PICU, 23/107 were considered to be bleeding during the first hour. Fibrinogen concentration had the best correlation with the amount of first-hour blood loss (r(s) = 0.52), followed by APTT (r(s) = 0.44) and TEG MA (r(s) = 0.34). TEG parameter TEG MA correlated with platelet count (r(s) = 0.68) and fibrinogen (r(s) = 0.66). CONCLUSIONS: Thromboelastography did not show better correlation with postoperative bleeding than conventional clotting tests. TEG parameter maximum amplitude correlates with platelet count and fibrinogen.


Subject(s)
Blood Coagulation , Cardiac Surgical Procedures/adverse effects , Cardiopulmonary Bypass/adverse effects , Fibrinogen/metabolism , Postoperative Hemorrhage/diagnosis , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Intensive Care Units, Pediatric , Male , Partial Thromboplastin Time , Platelet Count , Postoperative Hemorrhage/blood , Postoperative Hemorrhage/etiology , Prothrombin Time , Thrombelastography
4.
Respir Med ; 108(1): 71-7, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24172051

ABSTRACT

BACKGROUND: The presence of lipids in alveolar macrophages (AMs) may impair their phagocytic response, and determine airway inflammation and obstruction. OBJECTIVE: To determine the factors such as severity of asthma, chronic cough, airway inflammation and obesity that may influence the presence of lipids in lung macrophages. METHODS: Bronchoalveolar lavage fluid (BALF) was obtained from 38 asthmatics (21 severe and 17 mild/moderate), 16 subjects with chronic cough and 11 healthy control subjects. The presence of lipids in macrophages was detected using an Oil-red-O stain and an index of lipid-laden macrophages (LLMI) was obtained. RESULTS: LLMI scores were higher in healthy subjects (median 48 [IQR 10-61]) and the severe asthma group (37 [11.5-61]) compared to mild/moderate asthmatics (7 [0.5-37]; p < 0.05 each). Subjects reporting a history of gastro-oesophageal reflux disease (GORD) had higher LLMI values (41.5 [11.3-138] versus 13 [0-39.3], p = 0.02). There was no significant correlation between LLMI and chronic cough, BAL cell differential counts, FEV1, FEV1/FVC or body mass index (BMI). CONCLUSIONS: The reduced LLMI in mild/moderate asthma may be related to lower incidence of GORD. However, this was not related to the degree of airflow obstruction, obesity or airway inflammation.


Subject(s)
Asthma/pathology , Bronchoalveolar Lavage Fluid/chemistry , Cough/pathology , Lipids/analysis , Macrophages, Alveolar/chemistry , Adult , Asthma/metabolism , Body Mass Index , Bronchoalveolar Lavage Fluid/cytology , Bronchoscopy , Case-Control Studies , Cell Count , Chronic Disease , Female , Humans , Male , Middle Aged , Obesity/complications , Risk Factors , Severity of Illness Index
5.
J Cyst Fibros ; 12(1): 49-53, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22796637

ABSTRACT

BACKGROUND: Azithromycin is widely used as an immunomodulatory agent in the treatment of cystic fibrosis with previous literature documenting improvements in lung function and a reduction in infective exacerbations. The maximal study period in adults has been six months. METHODS: 81 adult patients taking continuous azithromycin were retrospectively identified. Percentage predicted FEV(1) and courses of intravenous antibiotics were examined at yearly intervals two years prior to and two years after azithromycin initiation. RESULTS: FEV(1) deteriorated in the two years before starting azithromycin by a mean of 2.02% per year. In the year following initiation, FEV(1) increased by 1.15% (P=0.01). However, a mean 2.58% reduction was observed in year two. There was no statistically significant effect on courses of intravenous antibiotics. CONCLUSIONS: Azithromycin resulted in an improved FEV(1) at year one. This effect was not sustained beyond the first year of treatment.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Azithromycin/administration & dosage , Cystic Fibrosis/drug therapy , Maintenance Chemotherapy , Adult , Ambulatory Care Facilities , Cystic Fibrosis/physiopathology , Female , Forced Expiratory Volume , Humans , Lung/drug effects , Male , Retrospective Studies , United Kingdom , Young Adult
6.
J Hum Hypertens ; 26(3): 157-63, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21390056

ABSTRACT

To report blood pressure control in the Hypertension in the Very Elderly Trial, a placebo-controlled trial of hypertensive (systolic blood pressure (SBP) 160-199 mm Hg, diastolic blood pressure (DBP) <110 mm Hg) participants over the age of 80 years, given treatment in three steps: indapamide slow release 1.5 mg alone, indapamide plus 2 mg perindopril and indapamide plus 4 mg perindopril. The difference in control between participants with combined systolic and diastolic hypertension (SDH, DBP90 mm Hg) and those with isolated systolic hypertension (ISH, DBP<90 mm Hg) is determined together with the effects of increments in the treatment regimen. At 2 years, the active treatment lowered blood pressure by 16.5/6.9 mm Hg more than that on placebo in participants with SDH and by 19.3/4.8 mm Hg more in those with ISH. The 2-year falls in pressure on placebo alone were 13.2/8.5 mm Hg in SDH and 8.2/1.5 mm Hg in ISH participants. With full titration of active treatment, 62% of SDH participants achieved goal SBP (<150 mm Hg) by 2 years and 71% of those with ISH. The corresponding results for DBP control (<80 mm Hg) were 40 and 78%. The addition of active perindopril 2 mg roughly doubled the percentage controlled, as did increasing to 4 from 2 mg. Blood pressure control was good with ISH and better than with SDH. The fall in SBP accounted for the observed 30% reduction in strokes, but the 21% reduction in total mortality and 64% reduction in heart failure were greater than predicted.


Subject(s)
Antihypertensive Agents/therapeutic use , Hypertension/drug therapy , Aged, 80 and over , Blood Pressure/drug effects , Drug Therapy, Combination , Female , Heart Failure/prevention & control , Humans , Indapamide/therapeutic use , Male , Perindopril/therapeutic use , Stroke/mortality , Stroke/prevention & control
7.
Anaesthesia ; 66(10): 901-6, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21883128

ABSTRACT

At the same time as cell salvage was introduced into our institution for all patients undergoing cardiac surgery with cardiopulmonary bypass, we established a supporting programme of quality assurance to reassure clinicians regarding safety and efficacy. Data collected in patients operated on between 2001 and 2007 included pre- and post-wash heparin concentration, haemoglobin concentration and free haemoglobin concentration. Cell salvage was used in 6826 out of a total of 7243 patients (94%). Post-wash heparin concentration was consistently low (always < 0.4 IU.ml(-1)). There was a significant decrease in post-wash haemoglobin concentration in 2003 compared to 2001, from a median (IQR [range]) of 19.6 (16.7-22.2 [12.9-25.5]) g.dl(-1) to 17.5 (13.6-20.8 [12.6-23.7]) g.dl(-1) (p < 0.015). In addition, there was a significant increase in free plasma haemoglobin in 2006 compared to 2001, from 0.5 (0.3-0.8 [0.1-2.6]) g.l(-1) to 0.8 (0.3-1.4 [0.3-5.2]) g.l(-1) (p < 0.001). This programme led to the detection of a change in operator behaviour in 2003 and progressive machine deterioration resulting in appropriate fleet replacement in 2006. You can respond to this article at http://www.anaesthesiacorrespondence.com.


Subject(s)
Cardiac Surgical Procedures/standards , Operative Blood Salvage/standards , Aged , Anticoagulants/therapeutic use , Blood Transfusion, Autologous/standards , Cardiac Surgical Procedures/economics , Cardiac Surgical Procedures/methods , Costs and Cost Analysis , Erythrocyte Transfusion/standards , Erythrocytes/physiology , Female , Hemoglobins/analysis , Heparin/therapeutic use , Humans , Male , Middle Aged , Operative Blood Salvage/economics , Quality Assurance, Health Care
8.
BMJ ; 342: d1008, 2011 Feb 28.
Article in English | MEDLINE | ID: mdl-21357627

ABSTRACT

OBJECTIVES: To evaluate the survival of patients with cystic fibrosis whose lung function has deteriorated to a forced expiratory volume in one second (FEV(1)) below 30% predicted in the recent treatment era and to explore factors associated with any change in survival. Design Cohort study. SETTING: Adult cystic fibrosis unit in London. PARTICIPANTS: 276 patients (147 (53%) male) whose FEV(1) was first observed to be less than 30% predicted between 1 January 1990 and 31 December 2003. MAIN OUTCOME MEASURE: Survival during follow-up to 31 December 2007 in two year sub-cohorts. RESULTS: Median survival improved from 1.2 years in the 1990-1 group to 5.3 years in the 2002-3 group, with a marked improvement in survival from 1994. The use of nebulised recombinant human DNase was significantly associated with a reduced risk of death (hazard ratio 0.59, 95% confidence interval 0.44 to 0.79). Significantly increased risks were associated with a body mass index under 19 (hazard ratio 1.52, 1.10 to 2.10), long term oxygen therapy (3.52, 2.49 to 4.99), and nebulised antibiotics (1.84, 1.05 to 3.22). CONCLUSION: A marked improvement has occurred in the survival of patients with cystic fibrosis with an FEV(1) less than 30% predicted. Secondary analyses suggest that some of this improvement may be due to use of recombinant human DNase.


Subject(s)
Cystic Fibrosis/mortality , Adult , Body Mass Index , Cystic Fibrosis/drug therapy , Cystic Fibrosis/physiopathology , Deoxyribonucleases/therapeutic use , Female , Forced Expiratory Volume/physiology , Humans , Kaplan-Meier Estimate , Male , Recombinant Proteins/therapeutic use , Risk Factors
9.
Clin Exp Allergy ; 31(11): 1672-8, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11696042

ABSTRACT

BACKGROUND: The rarity of atopy in traditional societies has been attributed to high parasite-driven blocking IgE concentrations. Information is lacking on the relationship between atopy, IgE and intestinal helminth infection in African populations. OBJECTIVE: To determine the prevalence of atopy and intestinal helminth infection and to relate these to wheeze history and serum total IgE in a community sample of adults from an urban (Banjul) and a rural (Farafenni) area of the Gambia. METHODS: Six hundred and ninety-three adults were interviewed about respiratory symptoms using a modified version of the IUTLD questionnaire, and had skin prick testing using four allergens. Stools were examined after formol-ether concentration. Total serum IgE concentration was measured in a subset of participants. RESULTS: The prevalence of atopy (mean weal diameter > or = 3 mm) in the urban and rural area was 35.3% and 22.5% (P = 0.05); D. pteronyssinus and Mold mix being the common sensitizing allergens. Prevalence of wheeze in the previous 12 months was 4.4% and 3.5% for the urban and rural areas, respectively. Wheezing was not significantly associated with atopy. Seventeen per cent of urban and 8.2% of rural subjects had helminths detected in stools. There was an inverse association between atopy and intestinal helminth infection; 7% of atopic subjects had helminths, compared to 13% of non-atopic subjects (unadjusted odds ratio 0.51, 95%CI 0.24-1.1, P = 0.09; adjusted odds ratio 0.37, 95%CI 0.15-0.92, P = 0.03). Non-atopics had total serum IgE concentrations about 2.5 times the upper limit of the reference range in non-atopic Western populations. Geometric mean total serum IgE concentration was significantly higher among atopic subjects (570 IU/mL, IQR 91-833) than non-atopic subjects (259 IU/mL, IQR 274-1303) (P < 0.001). IgE concentration was not associated with the presence of helminth infection. CONCLUSION: Further studies are needed to clarify why asthma is still relatively uncommon in spite of the prevalence of atopy in Gambian adults. Our data are also compatible with the idea that atopy might protect against helminth infection.


Subject(s)
Helminthiasis/blood , Helminthiasis/complications , Hypersensitivity, Immediate/blood , Hypersensitivity, Immediate/complications , Immunoglobulin E/blood , Intestinal Diseases, Parasitic/blood , Intestinal Diseases, Parasitic/complications , Adolescent , Adult , Asthma/complications , Asthma/epidemiology , Cross-Sectional Studies , Female , Gambia/epidemiology , Geography , Helminthiasis/epidemiology , Humans , Hypersensitivity, Immediate/epidemiology , Intestinal Diseases, Parasitic/epidemiology , Male , Prevalence , Random Allocation , Respiratory Sounds , Rural Health , Rural Population , Skin Tests , Urban Health
10.
Clin Exp Allergy ; 31(11): 1679-85, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11696043

ABSTRACT

BACKGROUND: Asthma is reported to be rare in traditional rural communities, but is thought to be increasing as lifestyles become more urbanized or 'western'. OBJECTIVES: A community-based survey of non-communicable diseases was conducted from October 1996 to June 1997, and included comparison of the prevalence of asthma, smoking and chronic cough in rural and urban Gambia. METHODS: A cluster sample survey was conducted in a random sample of rural and urban adults (> or = 15 years of age). Subjects were asked about respiratory symptoms using a locally adapted version based on the IULTD questionnaire. Spirometry (basal, methacholine provocation and reversibility with a bronchodilator) and skin prick tests were performed on a randomly selected subsample of all subjects and those who, when interviewed, said they wheezed or had been diagnosed as asthmatic by a doctor. RESULTS: Out of 2166 participants in the urban population, 4.1% reported having had wheezing or whistling in the chest in the previous 12 months, 3.6% reported doctor-diagnosed asthma, and 0.6% chronic cough. In the rural population with 3223 participants these figures were 3.3%, 0.7% and 1.2%, respectively. Wheeze was more common in women, cough for 3 months of the year was more common in the age-groups 45+. Those who reported that they currently smoked accounted for 34% in urban and 42% in rural men. Figures were much lower for women (1.5% and 6.0%). Seven out of 574 randomly selected subjects (1.4%) exhibited bronchial hyper-responsiveness to methacholine challenge. Four of 133 (3.0%) people with self-reported wheeze and 3/69 (4.3%) participants with doctor-diagnosed asthma reacted positively on bronchial provocation with methacholine. There was a remarkably high prevalence of positive skin prick tests to aeroallergens: 38% in participants with a history of wheeze and 27% in those without. CONCLUSION: The prevalence of wheeze (particularly in association with bronchial hyper-responsiveness) was low in both rural and urban Gambia. This is in contrast to the relatively high prevalence of positive skin prick tests to aeroallergens (in both wheezers and non-wheezers), questioning the mechanisms of interaction between allergy and asthma and the presence of protective factors against asthma in this West African population. The high smoking rates justify international concern about tobacco marketing in developing societies.


Subject(s)
Asthma/complications , Asthma/epidemiology , Cough/complications , Cough/epidemiology , Smoking/epidemiology , Adolescent , Adult , Age Factors , Asthma/genetics , Body Mass Index , Chronic Disease , Family Health , Female , Gambia/epidemiology , Humans , Male , Middle Aged , Prevalence , Random Allocation , Respiratory Sounds/genetics , Rural Health , Rural Population , Sex Factors , Surveys and Questionnaires , Urban Health
11.
J Hum Hypertens ; 15(10): 733-9, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11607805

ABSTRACT

Hypertension has become an important public health problem for sub-Sahara Africa. In a previous nationwide study, we observed a high degree of geographical variation in the prevalence of diastolic hypertension. Geographical variation provides essential background information for the development of community randomised trials could suggest aetiological mechanisms, inform control strategies and prompt further research questions. We designed a follow-up study from the nine high-prevalence communities, and from 18 communities where hypertension was found least prevalent (controls). In each community, 50 households were randomly selected. In each household, an (unrelated) man and woman were enrolled. The risk for hypertension (blood pressure > or =160/95 mm Hg) was higher in the high prevalence communities compared to the control villages (adjusted OR = 1.7, 95% CI 1.3-2.2). The observed coefficient of variation in hypertension prevalence, k, was 0.30. Thus we confirmed significant geographical variation in prevalence of hypertension over time, which has implications for planning of interventions.


Subject(s)
Hypertension/epidemiology , Adolescent , Adult , Female , Follow-Up Studies , Gambia/epidemiology , Humans , Hypertension/etiology , Male , Middle Aged , Obesity/epidemiology , Odds Ratio , Prevalence , Risk Assessment/statistics & numerical data , Risk Factors
12.
Am J Public Health ; 91(10): 1641-4, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11574327

ABSTRACT

OBJECTIVES: This study documented the prevalence of and cardiovascular risk factors associated with obesity and undernutrition in the Gambia. METHODS: Adults (> or =15 years; N = 5373) from rural and urban areas completed a questionnaire; their height, weight, and waist and hip circumferences were measured, and their cardiovascular risk factors were assessed. RESULTS: Prevalence of undernutrition (body mass index < 18 kg/m(2)) was 18.0%; all strata of society were affected. Prevalence of obesity (body mass index > or =30 kg/m(2)) was 4.0% but was higher (32.6%) among urban women 35 years or older. Cardiovascular risk factors were more prevalent among obese participants. CONCLUSIONS: Undernutrition coexists with obesity, demonstrating a "double burden of disease." Differential interventions should focus on high-risk groups; prevention needs a multisectorial approach.


Subject(s)
Cardiovascular Diseases/epidemiology , Nutrition Disorders/epidemiology , Obesity/epidemiology , Rural Health , Urban Health , Adolescent , Adult , Female , Gambia/epidemiology , Humans , Male , Middle Aged , Prevalence , Risk Factors , Surveys and Questionnaires
13.
J Health Popul Nutr ; 19(2): 59-65, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11503348

ABSTRACT

Placental malaria infection jeopardizes pregnancy outcome, and its influence may also impair the transplacental transfer of some antibodies. Two hundred and thirteen Gambian mother-baby pairs were studied to determine the influence of placental malaria infection and maternal hypergammaglobulinaemia on transplacental transfer of measles and tetanus antibodies in Gambian population. Placental blood and tissue were collected for placental malaria diagnosis. Cord and maternal sera were tested for total IgG concentration by laser nephelometry and for IgG antibody to tetanus toxoid and measles by ELISA. The prevalence of placental malaria infection was 51.1%. Mothers whose placentae were parasitized had a significantly higher mean total serum IgG (22.0 g/L vs 11.3 g/L, p < 0.001) and measles antibody level (4.02 IU/mL vs 1.21 IU/mL, p < 0.01), but not tetanus antibody, than mothers with non-parasitized placentae. Results of multiple regression analysis showed that placental malaria infection and maternal hypergammaglobulinaemia were associated with the reduction of 72% (95% CI 67.84) and 86% (95% CI 76.91) in transplacental transfer of measles antibody respectively but did not influence the transfer of tetanus antibody. It is concluded that the combined influence of placental malaria infection and maternal hypergammaglobulinaemia is significantly associated with the transfer of impaired measles antibody in this population.


Subject(s)
Hypergammaglobulinemia/immunology , Immunity, Maternally-Acquired , Malaria/immunology , Placenta/immunology , Pregnancy Complications/immunology , Adult , Antibodies/metabolism , Clostridium tetani/immunology , Female , Fetal Blood/immunology , Humans , Immunoglobulin G/blood , Infectious Disease Transmission, Vertical , Maternal-Fetal Exchange , Measles/immunology , Measles virus/immunology , Placenta/parasitology , Pregnancy , Pregnancy Complications/parasitology , Rural Health , Tetanus/immunology , Tetanus Toxoid/immunology
14.
J Infect Dis ; 184(5): 627-32, 2001 Sep 01.
Article in English | MEDLINE | ID: mdl-11494168

ABSTRACT

Two hundred thirteen mother-baby pairs in The Gambia were studied to determine the influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental antibody transfer. Antibody transfer for herpes simplex virus 1 (HSV-1), respiratory syncytial virus (RSV), and varicella-zoster virus (VZV) was significantly reduced by placental malaria infection by 69%, 58%, and 55%, respectively. Maternal hypergammaglobulinemia was associated with a significant reduction in antibody transfer for HSV-1, RSV, VZV, and pneumococcus by 89%, 90%, 91%, and 88%, respectively. In addition, placental malaria infection was associated with a significant reduction in transfer of IgG1, IgG2, and IgG4 (P<.01, P=.01, and P=.03, respectively) but not of IgG3 (P=.59). Maternal hypergammaglobulinemia significantly impaired the transfer of IgG1 and IgG2 (P=.01) but not of IgG3 or IgG4 (P=.62 and P=.59, respectively). Placental malaria infection and maternal hypergammaglobulinemia were associated with reduction in the transplacental transfer of these specific antibodies, IgG1, and IgG2 in this Gambian population.


Subject(s)
Antibodies, Bacterial/immunology , Antibodies, Viral/immunology , Hypergammaglobulinemia/immunology , Immunity, Maternally-Acquired/immunology , Malaria, Falciparum/immunology , Placenta Diseases/immunology , Pregnancy Complications, Parasitic/immunology , Adult , Animals , Antibodies, Bacterial/blood , Antibodies, Viral/blood , Female , Gambia , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Infant, Newborn , Male , Placenta/immunology , Placenta/parasitology , Plasmodium falciparum/isolation & purification , Pregnancy
15.
Bull World Health Organ ; 79(4): 321-8, 2001.
Article in English | MEDLINE | ID: mdl-11357211

ABSTRACT

OBJECTIVE: To examine whether a family history of high-risk groups for major noncommunicable diseases (NCDs) was a significant risk factor for these conditions among family members in a study population in the Gambia, where strong community and family coherence are important determinants that have to be taken into consideration in promoting lifestyle changes. METHODS: We questioned 5389 adults as to any first-degree family history of major noncommunicable diseases (hypertension, obesity, diabetes and stroke), and measured their blood pressure (BP) and body mass index (BMI). Total blood cholesterol, triglyceride, uric acid, and creatinine concentrations were measured in a stratified subsample, as well as blood glucose (2 hours after ingesting 75 g glucose) in persons aged > or = 35 years. FINDINGS: A significant number of subjects reported a family history of hypertension (8.0%), obesity (5.4%), diabetes (3.3%) and stroke (1.4%), with 14.6% of participants reporting any of these NCDs. Subjects with a family history of hypertension had a higher diastolic BP and BMI, higher cholesterol and uric acid concentrations, and an increased risk of obesity. Those with a family history of obesity had a higher BMI and were at increased risk of obesity. Individuals with a family history of diabetes had a higher BMI and higher concentrations of glucose, cholesterol, triglycerides and uric acid, and their risk of obesity and diabetes was increased. Subjects with a family history of stroke had a higher BMI, as well as higher cholesterol, triglyceride and uric acid concentrations. CONCLUSIONS: A family history of hypertension, obesity, diabetes, or stroke was a significant risk factor for obesity and hyperlipidaemia. With increase of age, more pathological manifestations can develop in this high-risk group. Health professionals should therefore utilize every opportunity to include direct family members in health education.


Subject(s)
Diabetes Mellitus/prevention & control , Family Health , Genetic Predisposition to Disease , Hypertension/prevention & control , Medical History Taking , Obesity/prevention & control , Adult , Diabetes Mellitus/epidemiology , Diabetes Mellitus/genetics , Female , Gambia/epidemiology , Humans , Hypertension/epidemiology , Hypertension/genetics , Middle Aged , Obesity/epidemiology , Obesity/genetics , Risk Factors
16.
Infect Immun ; 69(6): 3989-94, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11349068

ABSTRACT

The role of genetic factors in clinical tuberculosis is increasingly recognized; how such factors regulate the immune response to Mycobacterium tuberculosis in healthy individuals is unclear. In this study of 255 adult twin pairs residing in The Gambia, West Africa, it is apparent that memory T-cell responses to secreted mycobacterial antigens (85-kDa antigen complex, "short-term culture filtrate," and peptides from the ESAT-6 protein), as well as to the 65-kDa heat shock protein, are subject to effective genetic regulation. The delayed hypersensitivity response to intradermal tuberculin also demonstrates significant genetic variance, while quantitative T-cell and antibody responses to the 38-kDa cell membrane protein appear to be determined largely by environmental factors. Such findings have implications for vaccine development.


Subject(s)
Antigens, Bacterial/immunology , Diseases in Twins , Genetic Predisposition to Disease , Mycobacterium tuberculosis/immunology , Tuberculosis/genetics , Twins , Adolescent , Child , Female , Gambia , Humans , Interferon-gamma/metabolism , Lymphocyte Activation/immunology , Male , Skin Tests , T-Lymphocytes/immunology , Tuberculosis/immunology
18.
J Hum Hypertens ; 14(8): 489-96, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10962516

ABSTRACT

Hypertension is emerging as an important public health problem in sub-Saharan Africa. We studied blood pressure (BP) patterns, hypertension and other cardiovascular risk factors in a rural and an urban area of The Gambia. A total of 5389 adults (> or =15 years) were selected by cluster sampling in the capital Banjul and a rural area around Farafenni. A questionnaire was completed, BP, pulse rate, height and weight were recorded. Glucose was measured 2 h after a 75 g glucose load among participants > or =35 years (n = 2301); total cholesterol, triglycerides, creatinine and uric acid were measured among a stratified subsample (n = 1075). A total of 7.1% of the study participants had a BP > or =160/95 mm Hg; 18.4% of them had a BP > or =140/90 mm Hg. BP was significantly higher in the urban area. BP increased with age in both sexes in both areas. Increasing age was the major independent risk factor for hypertension. Related cardiovascular risk factors (obesity, diabetes and hyperlipidaemia) were significantly more prevalent in the urban area and among hypertensives; 17% of measured hypertensives were aware of this, 73% of people who reported to have been diagnosed as hypertensive before had discontinued treatment; 56% of those who reported being on treatment were normotensive. We conclude that hypertension is no longer rare in either urban or rural Gambians. In the urban site hypertension and related cardiovascular risk factors were more prevalent. Compliance with treatment was low. Interventions aimed at modifying risk factors at the population level, and at improving control of diagnosed hypertension are essential to prevent future increases of cardiovascular morbidity and mortality. In view of limited resources and feasibility of intervention in rural Gambia, these could initially be directed towards urbanised populations.


Subject(s)
Blood Pressure/physiology , Cardiovascular Diseases/etiology , Rural Health , Urban Health , Adolescent , Adult , Female , Gambia/epidemiology , Humans , Hypertension/drug therapy , Hypertension/epidemiology , Male , Patient Compliance , Prevalence , Risk Factors
19.
Pediatr Infect Dis J ; 19(5): 463-9, 2000 May.
Article in English | MEDLINE | ID: mdl-10819345

ABSTRACT

BACKGROUND: Unrelenting high morbidity and mortality have mandated that immunogenic vaccines be used to combat pneumococcal disease in infants. OBJECTIVES: To evaluate the safety and immunogenicity of a nonavalent pneumococcal conjugate vaccine and the antigenic interaction when administered simultaneously with diphtheria, tetanus and pertussis vaccines. METHODS: Two hundred seven infants were randomized to receive three doses of either nonavalent protein conjugate pneumococcal vaccine (PnCV) or inactivated polio vaccine (IPV) at 2, 3 and 4 months of age with routine Expanded Program of Immunization vaccines as scheduled. Vaccinees were visited on Days 1, 2 and 7 to observe local and systemic adverse reactions. Blood was drawn before the first dose and 1 month after the third dose. Antibody concentrations in sera were measured by standardized enzyme-linked immunosorbent assay. Nasopharyngeal carriage of pneumococci was tested at 5 and 9 months of age. RESULTS: No serious reactions were observed. Local induration and tenderness were observed more commonly at the site of administration of diphtheria, tetanus and pertussis vaccines than at the site of administration of IPV or PnCV. Between 79 and 91% achieved >1 microg/ml antibody against specific pneumococcal serotypes. Antibody responses to diphtheria and pertussis antigens were similar in both groups; however, antibody response to tetanus toxoid was significantly lower in infants who received PnCV (geometric mean concentration, 11.1 vs. 17.4; P < 0.001). Nasopharyngeal carriage in PnCV-vaccinated children was reduced but not significantly different from those vaccinated with IPV. CONCLUSION: Simultaneous administration of PnCV with Expanded Program of Immunization vaccines is safe and immunogenic. immune response to the composite antigens is likely to confer protection.


Subject(s)
Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage , Pneumococcal Infections/immunology , Pneumococcal Infections/prevention & control , Vaccines, Conjugate/administration & dosage , Vaccines, Conjugate/immunology , Antibodies, Bacterial/blood , Antigens, Bacterial/immunology , Bacterial Capsules/immunology , Bacterial Proteins/immunology , Drug Administration Routes , Drug Administration Schedule , Humans , Hypersensitivity/immunology , Infant , Nasopharynx/microbiology , Poliovirus Vaccine, Inactivated/administration & dosage , Serologic Tests , Treatment Outcome , Vaccines, Conjugate/adverse effects
20.
Ann Trop Paediatr ; 19(1): 33-43, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10605518

ABSTRACT

Childhood mortality in Upper River Division, The Gambia is high, 99 per 1000 mid-year population, and 27% of deaths occur is the neonatal period. The aims of the present study were to describe patterns of neonatal death and to identify risk factors. Cause of death was investigated using a neonatal post-mortem questionnaire, and a population-based, matched case-control study was conducted to identify potential risk factors. The neonatal mortality rate in Upper River Division was 39 per 1000 live births (95% CI 36.8-41.2). The rates in the early and late neonatal periods were 21.0 (19.4-22.6) and 18.0 (16.5-19.5), respectively. Infection accounted for 57% of all deaths. In the early neonatal period, 30% of deaths were due to prematurity. Only 55% of babies who died presented for treatment and 84% died at home. Risk factors for neonatal death were primiparity (OR 2.18), previous stillbirth (OR 3.19), prolonged labour (OR 2.80) and pre-lacteal feeding (OR 3.38). A protective effect was seen in association with delivery by a trained traditional birth attendant (OR 0.34) and the application of shea nut butter, a traditional medicine, to the cord stump (OR 0.07). This study has identified the need to understand the reasons underlying the widespread use of pre-lacteal feeds and the barriers to health service use in this community in order to plan effective interventions.


Subject(s)
Developing Countries , Infant Mortality , Rural Population/statistics & numerical data , Case-Control Studies , Cause of Death , Female , Gambia/epidemiology , Humans , Infant, Newborn , Male , Patient Acceptance of Health Care/statistics & numerical data , Risk Factors , Seasons , Sex Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...